AKR1C3 and neoplasm: Moreover, the cluster of EpCAM enriched cells were also enriched for several other genes of clinical interest including APOC1, a biomarker of tumor progression [34], ALDH1A1, a marker of tumor cell “stemness” [35], and AKR1C3, a marker of doxorubicin resistance [36].